CAPTIS™: MDD to MDR CER Remediation of a Standalone Software
Centre of Excellence Model to Streamline Nonclinical Data Processing and Presentation in Contributor Reports

Project Summary
A global biopharmaceutical company headquartered in San Francisco wanted to advance and streamline operations for its gene therapy program, including preparations of different types of reports but not limited to developmental, analytical, contributor reports and creation of in-house standard operating procedures (SOP).
Celegence Solution & Approach:
The biopharma client chose Celegence and its Center of Excellence (CoE) working model as the use of the CoE model allowed for integrated teams to be built, creating synergies between various non-clinical project activities. CASE I: The report template evolved as the customer’s team grew and new studies were performed. During the development of the first report from scratch, Celegence and the customer uncovered issues with their data. It required a different approach to reprocess the data. To help facilitate the issue, Celegence offered to help with the data and created a processing tool. In addition, a standard was developed based on known industry standards for data table presentation. For sample re-analysis, Celegence provided an acceptable framework for reporting the original and reprocessed data sets in a single report. CASE I: The report template evolved as the customer’s team grew and new studies were performed. During the development of the first report from scratch, Celegence and the customer uncovered issues with their data. It required a different approach to reprocess the data. To help facilitate the issue, Celegence offered to help with the data and created a processing tool. In addition, a standard was developed based on known industry standards for data table presentation. For sample re-analysis, Celegence provided an acceptable framework for reporting the original and reprocessed data sets in a single report. CASE II: In another case, a third-party vendor provided the results of their lab work, partly in the form of a large number of proprietary images in an unusable format. Celegence extended the support to address the issue and promptly located proprietary tools for the initial processing of the images. Celegence developed a method for processing many of the images into report-ready files with minimal loss of resolution. This saved the customer a great deal of time preparing the images for inclusion in the report.
Highlights:
The Celegence team first understood the current processes through multiple workshops in the different operational areas. The workshop helped the team develop an analysis of current vs desired outcomes and processes.
Discussion focused on Standard Operating Procedures (SOPs), Work Instructions (WI), and IT tools for performing activities related to various processes as well as roles and responsibilities of the resources. This analysis helped identify gaps in each area and establish the optimized processes, tools and roles. Subsequently, a proof-of-concept was conducted for each process area to evaluate the effectiveness of the newly enhanced processes.
Project Achievements
Across all RA activities, Celegence helped the client achieve its objectives and improve processes. A plan was promptly developed, and the lead consultant worked with the customer to create a report template. To achieve the Right First Time (RFT) approach, a QC checklist and standard formatting instructions were developed to maintain consistency across various reports, including the look and feel aspects of the documents. This helped to ensure that every document would be of top-notch quality and successful with minimum rework required in the future. Celegence has put in place a team of industry experts with deep nonclinical bioanalytical report-writing and data processing experience, thereby reducing the client’s internal resources burden. The Celegence team also established a roadmap for overall report development activity. This has helped to ensure consistency in how document workflow is managed over the period of report development activity.
Performance measurement through KPIs combined with budget control
Process consultancy and operational improvements for the overall program, leading to overall time reduction for operations by 50%
100% compliance to quality and timeline delivery performance despite tight timelines, an achievement that would not have been possible without Celegence’s expertise
Reduction in the total cost of ownership, including resources, tools and other operational costs
Improved compliance based on guidance from Celegence’s regulatory experts
Well-established communication and governance structure with open and transparent discussions
Project Success
The success of the partnership was due to the time committed to understanding goals and objectives through detailed workshops. This helped set the tone for the project and ensure quality outcomes from the delivery team. Furthermore, having a common understanding of requirements resulted in faster turnaround time and zero errors. Celegence’s global medical writing specialists are experts in the multiple therapeutic areas and product types, with in-depth knowledge of regulatory, clinical, and scientific contents perfectly integrated with technical, editorial and quality control capabilities. Our medical writers are well versed in working with various stakeholders such as clinical operations, data management, biostatistics, medical and safety teams. .
Get in touch
today to discuss your regulatory needs by reaching out to info@celegence.com or contact us online.
Learn MoreOther Related Articles
25 Mar, 2025
Contact Us Today
From document publishing automation to eCTD submissions and beyond, Celegence is your trusted partner for regulatory affairs excellence. Contact us to learn how we can help you achieve your compliance goals efficiently and cost-effectively.
"*" indicates required fields